Future trends in screening technology for drug discovery

被引:2
|
作者
Scheer, Alexander [1 ]
机构
[1] Serono Pharmaceut Res Inst, Dept Mol Screening & Cellular Pharmacol, Geneva, CH, Switzerland
关键词
affinity based screening; cellular imaging; high-throughput screening;
D O I
10.1517/17460441.1.3.195
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The last decade showed a further upsurge in screening technology advance and innovation. Notably, the establishment of ultra high-throughput screening facilities led to an explosion of screening capacities. However, in the last 2 years, a turning point in screening philosophy can be observed worldwide. Increasingly more companies are reducing the size of screening campaigns, while increasing the emphasis on data quality and relevance. This article tries to investigate how screening technologies will develop in the ever-changing landscape of drug discovery.
引用
收藏
页码:195 / 198
页数:4
相关论文
共 50 条
  • [1] Multimodal Screening - The Future of Drug Discovery and Development
    Cross B.C.S.
    Genetic Engineering and Biotechnology News, 2020, 40 (09): : 32 - 33
  • [2] Recent Trends and Future Prospects in Computational GPCR Drug Discovery: From Virtual Screening to Polypharmacology
    Carrieri, Antonio
    Perez-Nueno, Violeta I.
    Lentini, Giovanni
    Ritchie, David W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (09) : 1069 - 1097
  • [3] Drug discovery technology: The past, the present, and the future
    Lipinski, Chris
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [4] The latest trends in peptide drug discovery and future challenges
    Otvos, Laszlo
    EXPERT OPINION ON DRUG DISCOVERY, 2024, 19 (08) : 869 - 872
  • [5] Screening applications in drug discovery based on microfluidic technology
    Eribol, P.
    Uguz, A. K.
    Ulgen, K. O.
    BIOMICROFLUIDICS, 2016, 10 (01):
  • [6] Current and future developments of Markush technology in drug discovery
    Deng, David
    Figyelmesi, Arpad
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [7] Trends in ion channel drug discovery: advances in screening technologies
    Bennett, PB
    Guthrie, HRE
    TRENDS IN BIOTECHNOLOGY, 2003, 21 (12) : 563 - 569
  • [8] Bioorganometallics: Future Trends in Drug Discovery, Analytical Chemistry, and Catalysis
    Hillard, Elizabeth A.
    Jaouen, Gerard
    ORGANOMETALLICS, 2011, 30 (01) : 20 - 27
  • [9] Optimizing Drug Discovery by Investigative Toxicology: Current and Future Trends
    Beilmann, Mario
    Boonen, Harrie
    Czich, Andreas
    Dear, Gordon
    Hewitt, Philip
    Mow, Limas
    Newham, Peter
    Oinonen, Tea
    Pognan, Francois
    Roth, Adrian
    Valentin, Jean-Pierre
    Van Goethem, Freddy
    Weaver, Richard J.
    Birk, Barbara
    Boyer, Scott
    Caloni, Francesca
    Chen, Alice E.
    Corvi, Raffaella
    Cronin, Mark T. D.
    Daneshian, Manias
    Ewart, Lorna C.
    FitzGerald, Rex E.
    Hamilton, Geraldine A.
    Hartung, Thomas
    Kangas, Joshua D.
    Kramer, Nynke L.
    Leist, Marcel
    Marx, Uwe
    Polak, Sebastian
    Rovida, Costanza
    Testai, Emanuela
    van de Water, Bob
    Vulto, Paul
    Steger-Hartmann, Thomas
    ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION, 2019, 36 (02) : 289 - 313
  • [10] Phenotypic screening in cancer drug discovery — past, present and future
    John G. Moffat
    Joachim Rudolph
    David Bailey
    Nature Reviews Drug Discovery, 2014, 13 : 588 - 602